BioAge Labs Q1 2026 Earnings EPS Beat on Lower Loss PreRevenue Stage Continues GHRS Q1 2026 Earnings WiderthanExpected Loss Underscores ClinicalStage Challenges IOVA Q1 2026 Earnings EPS Miss Becomes a Buying Opportunity as Shares Jump GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development BAH Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction